Eli Lilly’s weight-loss pill didn’t work so well, and the stock is plunging
Lilly’s stock was tumbling as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
Trending
- BREAKING: Authorities Concern A number of Deaths After Jet Owned By Greg Biffle Goes Down Close to Runway
- Miranda Devine: The Self-importance Honest interview was a ‘targeted’ hit job on Susie Wiles, whole Trump admin
- The place the wild issues thrive: Discovering and defending nature’s local weather change protected havens
- Donut Lab’s hub motor meets WATT’s battery to create new EV skateboard
- Abortions Improve as Abortion Capsules Flourish, Democrat States Fund Killing Infants
- WATCH: Trump Contrasts 12 months One Wins With Biden’s Failures In White House Tackle
- Palantir & The Risks It Presents Not Simply To People However The World (Video) – The Washington Commonplace
- Santa Claus goes straight to the NFL: Snoop Dogg to carry out for Lions-Vikings on Christmas
- BREAKING: Trump pronounces $1,776 ‘warrior dividend’ for 1.45 million troops forward of Christmas
- JUST IN: U.S. Service Members Will Obtain $1776 ‘Warrior Dividend’ For Christmas, Trump Says